Literature DB >> 19515869

Disappearance of vaccine-type invasive pneumococcal disease and emergence of serotype 19A in a minority population with a high prevalence of human immunodeficiency virus and low childhood immunization rates.

Azadeh Tasslimi1, Erica J Sison, Elizabeth Story, David Alland, Michele Burday, Susan Morrison, Sandhya Nalmas, Stephen Smith, Pauline A Thomas, Peter Wenger, Anushua Sinha.   

Abstract

We analyzed the epidemiology of invasive pneumococcal disease (IPD) following introduction of pneumococcal conjugated vaccine in an urban population with a 2% human immunodeficiency virus (HIV) prevalence and history of low childhood immunization rates. We observed near-elimination of vaccine-type IPD. Substantial disease remains due to non-vaccine-type pneumococci, highlighting the need to increase pneumococcal immunization among HIV-infected adults.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19515869      PMCID： PMC2725536          DOI： 10.1128/CVI.00140-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  13 in total

1.  Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era.

Authors:  K A Robinson; W Baughman; G Rothrock; N L Barrett; M Pass; C Lexau; B Damaske; K Stefonek; B Barnes; J Patterson; E R Zell; A Schuchat; C G Whitney
Journal:  JAMA       Date:  2001-04-04       Impact factor: 56.272

2.  Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-09-16       Impact factor: 17.586

3.  Changes in invasive Pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization.

Authors:  Brendan Flannery; Richard T Heffernan; Lee H Harrison; Susan M Ray; Arthur L Reingold; James Hadler; William Schaffner; Ruth Lynfield; Ann R Thomas; Jianmin Li; Michael Campsmith; Cynthia G Whitney; Anne Schuchat
Journal:  Ann Intern Med       Date:  2006-01-03       Impact factor: 25.391

4.  Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States.

Authors:  Rekha Pai; Matthew R Moore; Tamara Pilishvili; Robert E Gertz; Cynthia G Whitney; Bernard Beall
Journal:  J Infect Dis       Date:  2005-11-01       Impact factor: 5.226

5.  Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.

Authors:  Cynthia G Whitney; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Ruth Lynfield; Arthur Reingold; Paul R Cieslak; Tamara Pilishvili; Delois Jackson; Richard R Facklam; James H Jorgensen; Anne Schuchat
Journal:  N Engl J Med       Date:  2003-05-01       Impact factor: 91.245

6.  Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage.

Authors:  Rosalyn J Singleton; Thomas W Hennessy; Lisa R Bulkow; Laura L Hammitt; Tammy Zulz; Debby A Hurlburt; Jay C Butler; Karen Rudolph; Alan Parkinson
Journal:  JAMA       Date:  2007-04-25       Impact factor: 56.272

7.  Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections.

Authors:  Brendan Flannery; Stephanie Schrag; Nancy M Bennett; Ruth Lynfield; Lee H Harrison; Arthur Reingold; Paul R Cieslak; James Hadler; Monica M Farley; Richard R Facklam; Elizabeth R Zell; Cynthia G Whitney
Journal:  JAMA       Date:  2004-05-12       Impact factor: 56.272

8.  Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.

Authors:  Matthew R Moore; Robert E Gertz; Robyn L Woodbury; Genevieve A Barkocy-Gallagher; William Schaffner; Catherine Lexau; Kenneth Gershman; Arthur Reingold; Monica Farley; Lee H Harrison; James L Hadler; Nancy M Bennett; Ann R Thomas; Lesley McGee; Tamara Pilishvili; Angela B Brueggemann; Cynthia G Whitney; James H Jorgensen; Bernard Beall
Journal:  J Infect Dis       Date:  2008-04-01       Impact factor: 5.226

9.  Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.

Authors:  Allison F Messina; Kathy Katz-Gaynor; Theresa Barton; Naveed Ahmad; Faryal Ghaffar; David Rasko; George H McCracken
Journal:  Pediatr Infect Dis J       Date:  2007-06       Impact factor: 2.129

10.  Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.

Authors:  Stephen I Pelton; Heather Huot; Jonathan A Finkelstein; C J Bishop; Katherine K Hsu; Joan Kellenberg; Susan S Huang; Richard Goldstein; William P Hanage
Journal:  Pediatr Infect Dis J       Date:  2007-06       Impact factor: 2.129
View more
  1 in total

1.  Cost-effectiveness of pneumococcal conjugate vaccination in immunocompromised adults.

Authors:  Kenneth J Smith; Mary Patricia Nowalk; Mahlon Raymund; Richard K Zimmerman
Journal:  Vaccine       Date:  2013-06-24       Impact factor: 3.641
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.